Table 3.
BL | F1 | F3 | F6 | F12 | |
---|---|---|---|---|---|
All | |||||
Total | 2056 | 2034 | 1899 | 1833 | 1766 |
Death, n (%) | 8 (0.4) | 29 (1.4) | 70 (3.7) | 100 (5.5) | 128 (7.3) |
Reason for death | |||||
Missing/unknown | – | 7 (24.1) | 14 (20.0) | 20 (20.0) | 23 (18.0) |
VTE-related death | 1 (12.5) | 1 (3.4) | 2 (2.9) | 3 (3.0) | 4 (3.1) |
Cardiovascular death | – | 2 (6.9) | 4 (5.7) | 7 (7.0) | 9 (7.0) |
Other | 7 (87.5) | 19 (65.5) | 50 (71.4) | 70 (70.0) | 92 (71.9) |
Patients without active cancer | |||||
Total | 1882 | 1862 | 1736 | 1673 | 1610 |
Death, n (%) | 5 (0.3)% | 15 (0.8) | 29 (1.7) | 40 (2.4) | 61 (3.8) |
Reason for death | |||||
Missing/unknown | – | 3 (20.0) | 6 (20.7) | 7 (17.5) | 10 (16.4) |
VTE-related death | 1 (20.0)% | 1 (6.7) | 2 (6.9) | 2 (5.0) | 2 (3.3) |
Cardiovascular death | – | 2 (13.3) | 3 (10.3) | 5 (12.5) | 7 (11.5) |
Other | 4 (80.0)% | 9 (60.0) | 18 (62.1) | 26 (65.0) | 42 (68.9) |
Patients with active cancer | |||||
Total | 174 | 172 | 163 | 160 | 156 |
Death, n (%) | 3 (1.7) | 14 (8.1) | 41 (25.2) | 60 (37.5) | 67 (43.0) |
Reason for death | |||||
Missing/unknown | – | 4 (28.6) | 8 (19.5) | 14 (23.3) | 13 (19.4) |
VTE-related death | – | – | – | 1 (1.7) | 2 (3.0) |
Cardiovascular death | – | – | 1 (2.4) | 2 (3.3) | 2 (3.0) |
Other | 3 (100.0) | 10 (71.4) | 32 (78.0) | 44 (73.3) | 50 (74.6) |
Abbreviations: BL, baseline; F1, 1 month follow-up; F3, 3 months follow-up; F6, 6 months follow-up; F12, 12 months follow-up.